The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

By P. Dorian, W. Jung, D. Newman, M. Paquette, Kathryn J. Wood, G. Ayers, J. Camm, Masood Akhtar, B. Lüderitz. Journal of the American College of Cardiology, 2000

648 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine

View Paper: https://www.semanticscholar.org/paper/4b424548045e3f26c6b1bb666ce3eb0392f3da65

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

Citations in the corpus

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017, background): “%) and was associated with a lower rate of unplanned hospitalization.529 Taken as a whole, the results of these studies suggest that catheter ablation of AF is safe and effective in selected patients with HF.”
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. (2016, neutral): “Patients with AF have significantly poorer quality of life than healthy controls, experiencing a variety of symptoms including lethargy, palpitations, dyspnoea, chest tightness, sleeping difficulties, and psychosocial distress.(32,177) – 180 Improved quality of life Table 6 Clinical types of atrial ”
Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. (2014, methodology): “AF symptom burden and severity were quantified by using the validated Atrial Fibrillation Severity Scale (AFSS, University of Toronto, Toronto, Ontario, Canada) (24).”
The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. (2014, background): “These impairments are comparable or worse than those in patients with HF or coronary heart disease (postcoronary angioplasty and postmyocardial infarction cohorts).(104) Although studies have demonstrated significantly improved QOL after therapeutic intervention, in general there does not seem to be”
Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). (2015, methodology): “AF symptom burden was determined by the AF Severity Scale (AFSS) (University of Toronto, Toronto, Ontario, Canada), which quantitates 3 domains of AF-related symptoms: frequency, duration, and severity (18).”
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design (2012, background): “Patients with AF, as reflected by standardized SF36 scores, have substantially impaired QOL, below population norms, and comparable to patients with coronary artery disease and congestive heart failure [526, 527, 530].”